Latest filing published 27 Aug 2026 for Fulgent Genetics, Inc., €20k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Xie Jian in Fulgent Genetics, Inc. In total, 2 filings cover trades dated from 2 June 2026 to 27 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 27 August 2026, the filings show a transaction worth €20k in Fulgent Genetics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.